- Adoptive Immunotherapy for Cytomegalovirus (CMV) Disease in Immunocompromised Patients
-
Lim JB, Kwon OH, Kim HS, Kim HO, Choi JR, Provenzano M, Stroncek D
- KMID: 1726140
- Yonsei Med J.
- 2004 Jun;45(Suppl):S18-S22.
- doi: 10.3349/ymj.2004.45.Suppl.18
Cytomegalovirus (CMV) reactivation in immune compromised patients such as those undergoing hematopoietic progenitor cell transplantation (HPCT) and those with HIV infections can cause severe morbidity and mortality despite treatment with... -
- CITED
-
- Close
- SHARE
-
- Close
- Understanding of molecular mechanisms in natural killer cell therapy
-
Yoon SR, Kim TD, Choi I
- KMID: 2155406
- Exp Mol Med.
- 2015 Feb;47(2):e141.
- doi: 10.1038/emm.2014.114
Cancer cells and the immune system are closely related and thus influence each other. Although immune cells can suppress cancer cell growth, cancer cells can evade immune cell attack via... -
- CITED
-
- Close
- SHARE
-
- Close
- In vitro induction of anterior gradient-2-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses as a potential therapy for colorectal cancer
-
Lee HJ, Hong CY, Kim MH, Lee YK, Nguyen-Pham TN, Park BC, Yang DH, Chung IJ, Kim HJ, Lee JJ
- KMID: 1120143
- Exp Mol Med.
- 2012 Jan;44(1):60-67.
- doi: 10.3858/emm.2012.44.1.006
Anterior gradient-2 (AGR2) promotes tumor growth, cell migration, and cellular transformation, and is one of the specific mRNA markers for circulating tumor cells in patients with gastrointestinal cancer. We investigated... -
- CITED
-
- Close
- SHARE
-
- Close
